AUD 0.02
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 5.52 Million AUD | 191.96% |
2023 | 1.89 Million AUD | 35.53% |
2022 | 1.39 Million AUD | -37.0% |
2021 | 2.21 Million AUD | -1.85% |
2020 | 2.25 Million AUD | -47.95% |
2019 | 4.33 Million AUD | 3.01% |
2018 | 4.2 Million AUD | -8.09% |
2017 | 4.57 Million AUD | 10.8% |
2016 | 4.13 Million AUD | 41.83% |
2015 | 2.91 Million AUD | 18.44% |
2014 | 2.45 Million AUD | 10.46% |
2013 | 2.22 Million AUD | -20.33% |
2012 | 2.79 Million AUD | -20.09% |
2011 | 3.49 Million AUD | 25.12% |
2010 | 2.79 Million AUD | -10.76% |
2009 | 3.13 Million AUD | -9.47% |
2008 | 3.46 Million AUD | -32.31% |
2007 | 5.11 Million AUD | -0.9% |
2006 | 5.15 Million AUD | 29.97% |
2005 | 3.96 Million AUD | 0.0% |
2003 | - AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 906.54 Thousand AUD | 0.0% |
2024 Q4 | 2.97 Million AUD | 0.0% |
2024 FY | 1.97 Million AUD | 4.63% |
2023 FY | 1.89 Million AUD | 35.53% |
2023 Q4 | 948.79 Thousand AUD | 0.0% |
2023 Q2 | 941.89 Thousand AUD | 0.0% |
2022 Q4 | 710.61 Thousand AUD | 0.0% |
2022 FY | 1.39 Million AUD | -37.0% |
2022 Q2 | 684.44 Thousand AUD | 0.0% |
2021 Q2 | 1.31 Million AUD | 0.0% |
2021 Q4 | 899.9 Thousand AUD | 0.0% |
2021 FY | 2.21 Million AUD | -1.85% |
2020 FY | 2.25 Million AUD | -47.95% |
2020 Q4 | 1.14 Million AUD | 0.0% |
2020 Q2 | 1.1 Million AUD | 0.0% |
2019 FY | 4.33 Million AUD | 3.01% |
2019 Q4 | 1.44 Million AUD | 0.0% |
2019 Q2 | 1.98 Million AUD | 0.0% |
2018 Q4 | 2.04 Million AUD | 0.0% |
2018 FY | 4.2 Million AUD | -8.09% |
2018 Q2 | 2.15 Million AUD | 0.0% |
2017 Q2 | 2.44 Million AUD | 0.0% |
2017 Q4 | 2.13 Million AUD | 0.0% |
2017 FY | 4.57 Million AUD | 10.8% |
2016 FY | 4.13 Million AUD | 41.83% |
2016 Q4 | 2.11 Million AUD | 0.0% |
2016 Q2 | 2.01 Million AUD | 0.0% |
2015 FY | 2.91 Million AUD | 18.44% |
2015 Q2 | 1.3 Million AUD | 0.0% |
2015 Q4 | 1.6 Million AUD | 0.0% |
2014 Q1 | 33.82 Thousand AUD | -96.9% |
2014 FY | 2.45 Million AUD | 10.46% |
2014 Q4 | 1.57 Million AUD | 4273.15% |
2014 Q3 | 35.92 Thousand AUD | -96.71% |
2014 Q2 | 1.09 Million AUD | 3127.95% |
2013 FY | 2.22 Million AUD | -20.33% |
2013 Q4 | 1.09 Million AUD | 3122.48% |
2013 Q3 | 33.82 Thousand AUD | 0.0% |
2013 Q2 | 33.82 Thousand AUD | 20.2% |
2013 Q1 | 28.14 Thousand AUD | 0.0% |
2012 Q3 | 28.14 Thousand AUD | 0.0% |
2012 Q4 | - AUD | -100.0% |
2012 FY | 2.79 Million AUD | -20.09% |
2012 Q1 | 31.6 Thousand AUD | 0.0% |
2012 Q2 | 28.14 Thousand AUD | -10.95% |
2011 Q2 | 31.6 Thousand AUD | -4.76% |
2011 Q4 | - AUD | -100.0% |
2011 FY | 3.49 Million AUD | 25.12% |
2011 Q1 | 33.18 Thousand AUD | 0.0% |
2011 Q3 | 31.6 Thousand AUD | 0.0% |
2010 FY | 2.79 Million AUD | -10.76% |
2010 Q4 | - AUD | -100.0% |
2010 Q3 | 33.18 Thousand AUD | 0.0% |
2010 Q1 | 30.91 Thousand AUD | 0.0% |
2010 Q2 | 33.18 Thousand AUD | 7.34% |
2009 Q4 | - AUD | -100.0% |
2009 FY | 3.13 Million AUD | -9.47% |
2009 Q2 | 30.91 Thousand AUD | -1.78% |
2009 Q3 | 30.91 Thousand AUD | 0.0% |
2009 Q1 | 31.47 Thousand AUD | 0.0% |
2008 Q4 | - AUD | -100.0% |
2008 Q3 | 31.47 Thousand AUD | 0.0% |
2008 FY | 3.46 Million AUD | -32.31% |
2008 Q1 | 27.59 Thousand AUD | 0.0% |
2008 Q2 | 31.47 Thousand AUD | 14.05% |
2007 Q4 | - AUD | -100.0% |
2007 FY | 5.11 Million AUD | -0.9% |
2007 Q3 | 27.59 Thousand AUD | 0.0% |
2007 Q2 | 27.59 Thousand AUD | -1.69% |
2007 Q1 | 28.07 Thousand AUD | 0.0% |
2006 FY | 5.15 Million AUD | 29.97% |
2006 Q2 | 28.07 Thousand AUD | 81.86% |
2006 Q4 | - AUD | -100.0% |
2006 Q3 | 28.07 Thousand AUD | 0.0% |
2006 Q1 | 15.43 Thousand AUD | 0.0% |
2005 FY | 3.96 Million AUD | 0.0% |
2005 Q2 | 15.43 Thousand AUD | 0.0% |
2005 Q4 | - AUD | -100.0% |
2005 Q3 | 15.43 Thousand AUD | 0.0% |
2004 Q1 | - AUD | 0.0% |
2003 Q4 | - AUD | 0.0% |
2003 FY | - AUD | 0.0% |
2003 Q2 | - AUD | 0.0% |
2003 Q3 | - AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 82.467% |
Adherium Limited | 267.7 Thousand AUD | -1962.003% |
Aroa Biosurgery Limited | 66.09 Million AUD | 91.649% |
Atomo Diagnostics Limited | 1.6 Million AUD | -243.713% |
Anteris Technologies Ltd | 69.14 Million AUD | 92.017% |
Control Bionics Limited | 9.82 Million AUD | 43.822% |
CardieX Limited | 16.64 Million AUD | 66.845% |
Compumedics Limited | 26.88 Million AUD | 79.464% |
Cochlear Limited | 1.17 Billion AUD | 99.53% |
CleanSpace Holdings Limited | 11.35 Million AUD | 51.405% |
Cyclopharm Limited | 13.38 Million AUD | 58.747% |
EMVision Medical Devices Ltd | 12.83 Million AUD | 56.988% |
Nova Eye Medical Limited | 23.99 Million AUD | 76.99% |
HeraMED Limited | 6.78 Million AUD | 18.619% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 594.699% |
ImpediMed Limited | 28.04 Million AUD | 80.314% |
InhaleRx Limited | 2.59 Million AUD | -113.085% |
LBT Innovations Limited | 1.1 Million AUD | -398.649% |
Micro-X Limited | 18.76 Million AUD | 70.582% |
Neurotech International Limited | 8.75 Million AUD | 36.945% |
OncoSil Medical Limited | 12.03 Million AUD | 54.152% |
PolyNovo Limited | 34.92 Million AUD | 84.193% |
Respiri Limited | 8.03 Million AUD | 31.299% |
SomnoMed Limited | 58.97 Million AUD | 90.64% |
Universal Biosensors, Inc. | 20 Million AUD | 72.4% |
Visioneering Technologies, Inc. | 9.63 Million AUD | 42.7% |